JEFF THOMAS: Open Payments
NPI 1013281609 · NORTH LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$835 in 49 payments from 10 companies in 2025. Trend: 2023 $997 · 2024 $455 · 2025 $835
Food & beverage: $835
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 23 | $283 |
| Novartis Pharmaceuticals Corporation | 11 | $190 |
| Myriad Genetic Laboratories, Inc. | 3 | $124 |
| PFIZER INC. | 3 | $62 |
| Dendreon Pharmaceuticals LLC | 2 | $40 |
| ABBVIE INC. | 2 | $38 |
| Janssen Biotech, Inc. | 2 | $37 |
| Teleflex LLC | 1 | $28 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| TOLMAR, INC. | 1 | $14 |
Products named: PLUVICTO, ORGOVYX, PROLARIS, GEMTESA, XTANDI, PROVENGE, BOTOX, ERLEADA.
Industry payments across AR — which companies pay providers there.
